Determination of palonosetron in human plasma by liquid chromatography–electrospray ionization-mass spectrometry
Authors:
- 28 June 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 44 (2) , 575-580
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Determination of azelnidipine in human plasma by liquid chromatography–electrospray ionization-mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Sensitive HPLC–APCI–MS method for the determination of cyclovirobuxine D in human plasmaJournal of Chromatography B, 2006
- A sensitive LC–ESI-MS method for the determination of indapamide in human plasma: Method and clinical applicationsJournal of Pharmaceutical and Biomedical Analysis, 2006
- Determination of glycyrrhetic acid in human plasma by LC–ESI–MSJournal of Pharmaceutical and Biomedical Analysis, 2006
- Determination of moxonidine in human plasma by liquid chromatography–electrospray ionisation–mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2006
- Pharmacokinetic and Safety Evaluation of Palonosetron, a 5‐Hydroxytryptamine‐3 Receptor Antagonist, in U.S. and Japanese Healthy SubjectsThe Journal of Clinical Pharmacology, 2004
- Simultaneous determination of sibutramine and its N-desmethyl metabolites in human plasma by liquid chromatography–electrospray ionization–mass spectrometryAnalytica Chimica Acta, 2003
- 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and VomitingDrugs, 1998